| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |